237 related articles for article (PubMed ID: 20735753)
1. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
Safarpour D; Jabbari B
Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study.
Safarpour D; Salardini A; Richardson D; Jabbari B
Pain Med; 2010 Sep; 11(9):1411-4. PubMed ID: 20609130
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
[TBL] [Abstract][Full Text] [Related]
4. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
Kharkar S; Ambady P; Venkatesh Y; Schwartzman RJ
Pain Physician; 2011; 14(5):419-24. PubMed ID: 21927045
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous botulinum toxin A for the treatment of refractory complex regional pain syndrome.
Birthi P; Sloan P; Salles S
PM R; 2012 Jun; 4(6):446-9. PubMed ID: 22732156
[No Abstract] [Full Text] [Related]
7. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
Yoshida K
Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
[TBL] [Abstract][Full Text] [Related]
8. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
Laskin DM
Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
[TBL] [Abstract][Full Text] [Related]
9. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
Desai MJ; Shkolnikova T; Nava A; Inwald D
Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
[TBL] [Abstract][Full Text] [Related]
10. Complex regional pain syndrome-like symptoms during herpes zoster.
Berry JD; Rowbotham MC; Petersen KL
Pain; 2004 Jul; 110(1-2):e1-12. PubMed ID: 15275746
[TBL] [Abstract][Full Text] [Related]
11. The effect of small doses of botulinum toxin a on neck-shoulder myofascial pain syndrome: a double-blind, randomized, and controlled crossover trial.
Ojala T; Arokoski JP; Partanen J
Clin J Pain; 2006 Jan; 22(1):90-6. PubMed ID: 16340597
[TBL] [Abstract][Full Text] [Related]
12. Myofascial Pain.
Weller JL; Comeau D; Otis JAD
Semin Neurol; 2018 Dec; 38(6):640-643. PubMed ID: 30522139
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin (BoNT) and back pain.
Porta M; Maggioni G
J Neurol; 2004 Feb; 251 Suppl 1():I15-8. PubMed ID: 14991338
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
15. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects?
Hsieh RL; Lee WC
Arch Phys Med Rehabil; 2008 Apr; 89(4):792-3; author reply 793. PubMed ID: 18374016
[No Abstract] [Full Text] [Related]
16. [Treatment of myofascial pain syndrome (MPS) with botulinum toxin type A (BoNT-A)].
Günther O; Bitterlich N
MMW Fortschr Med; 2011 Jul; 153 Suppl 2():64-9. PubMed ID: 23964470
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
Ho KY; Tan KH
Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study.
Ketenci A; Basat H; Esmaeilzadeh S
Agri; 2009 Jul; 21(3):95-103. PubMed ID: 19780000
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of PrabotulinumtoxinA (Nabota
Kim DY; Kim JM
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30177597
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A and myofascial pain syndrome: a retrospective study of 301 patients.
Avendaño-Coy J; Gómez-Soriano J; Valencia M; Estrada J; Leal F; Ruiz-Campa R
J Back Musculoskelet Rehabil; 2014; 27(4):485-92. PubMed ID: 24867895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
